Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ovacik MA"'
Autor:
Li R; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA. li.ran@gene.com., Dere E; Safety Assessment, Genentech Inc., South San Francisco, California, 94080, USA., Kwong M; Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, California, 94080, USA., Fei M; Molecular Oncology, Genentech Inc, South San Francisco, California, 94080, USA., Dave R; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Masih S; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Wang J; Molecular Oncology, Genentech Inc, South San Francisco, California, 94080, USA., McNamara E; Molecular Oncology, Genentech Inc, South San Francisco, California, 94080, USA., Huang H; Molecular Oncology, Genentech Inc, South San Francisco, California, 94080, USA., Liang WC; Antibody Engineering, Genentech Inc, South San Francisco, California, 94080, USA., Schutt L; Safety Assessment, Genentech Inc., South San Francisco, California, 94080, USA., Kamath AV; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Ovacik MA; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA. ovacik.ayse_meric@gene.com.
Publikováno v:
The AAPS journal [AAPS J] 2024 Jan 02; Vol. 26 (1), pp. 11. Date of Electronic Publication: 2024 Jan 02.
Autor:
Cai H; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA. cai.hao@gene.com., Kakiuchi-Kiyota S; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Hendricks R; BioAnalytical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Zhong S; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Liu L; BioAnalytical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Adedeji AO; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Chan P; Biochemical Cellular Pharmacology, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Schutten MM; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Kamath AV; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA., Ovacik MA; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA. ovacik.ayse_meric@gene.com.
Publikováno v:
The AAPS journal [AAPS J] 2022 Sep 20; Vol. 24 (6), pp. 100. Date of Electronic Publication: 2022 Sep 20.
Autor:
Yadav R; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Sukumaran S; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Zabka TS; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Li J; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Oldendorp A; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Morrow G; Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Reyes A; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Cheu M; BioAnalytical Sciences, Genentech Inc., South San Francisco, CA 94080, USA., Li J; Oncology Biomarker Development (OBD), Genentech Inc., South San Francisco, CA 94080, USA., Wallin JJ; Oncology Biomarker Development (OBD), Genentech Inc., South San Francisco, CA 94080, USA., Tsai S; Biochemical and Cellular Pharmacology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Sun L; Translational Oncology Department, Genentech Inc., South San Francisco, CA 94080, USA., Wang P; Translational Oncology Department, Genentech Inc., South San Francisco, CA 94080, USA., Ellerman D; Antibody Engineering, Genentech Inc., South San Francisco, CA 94080, USA., Spiess C; Antibody Engineering, Genentech Inc., South San Francisco, CA 94080, USA., Polson A; Translational Oncology Department, Genentech Inc., South San Francisco, CA 94080, USA., Stefanich EG; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Kamath AV; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Ovacik MA; Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2022 Apr 30; Vol. 14 (5). Date of Electronic Publication: 2022 Apr 30.
Autor:
Dillon M; a Department of Antibody Engineering , Genentech, Inc. , South San Francisco , CA , USA., Yin Y; a Department of Antibody Engineering , Genentech, Inc. , South San Francisco , CA , USA., Zhou J; a Department of Antibody Engineering , Genentech, Inc. , South San Francisco , CA , USA., McCarty L; b Department of Protein Chemistry , Genentech, Inc. , South San Francisco , CA , USA., Ellerman D; b Department of Protein Chemistry , Genentech, Inc. , South San Francisco , CA , USA., Slaga D; c Department of Translational Oncology , Genentech, Inc. , South San Francisco , CA , USA., Junttila TT; c Department of Translational Oncology , Genentech, Inc. , South San Francisco , CA , USA., Han G; d Department of Microchemistry, Proteomics and Lipidomics , Genentech, Inc. , South San Francisco , CA , USA., Sandoval W; d Department of Microchemistry, Proteomics and Lipidomics , Genentech, Inc. , South San Francisco , CA , USA., Ovacik MA; e Department of Preclinical and Translational Pharmacokinetics , Genentech, Inc. , South San Francisco , CA , USA., Lin K; e Department of Preclinical and Translational Pharmacokinetics , Genentech, Inc. , South San Francisco , CA , USA., Hu Z; f Department of Early Stage Cell Culture , Genentech, Inc. , South San Francisco , CA , USA., Shen A; f Department of Early Stage Cell Culture , Genentech, Inc. , South San Francisco , CA , USA., Corn JE; g Department of Early Discovery Biochemistry, Genentech, Inc. , South San Francisco , CA , USA., Spiess C; a Department of Antibody Engineering , Genentech, Inc. , South San Francisco , CA , USA., Carter PJ; a Department of Antibody Engineering , Genentech, Inc. , South San Francisco , CA , USA.
Publikováno v:
MAbs [MAbs] 2017 Feb/Mar; Vol. 9 (2), pp. 213-230. Date of Electronic Publication: 2016 Dec 08.
Autor:
Ait-Oudhia S; a Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics , College of Pharmacy, University of Florida , Orlando , FL , USA., Ovacik MA; b Department of Pharmaceutical Sciences , University at Buffalo, State University of New York , Buffalo , NY , USA., Mager DE; b Department of Pharmaceutical Sciences , University at Buffalo, State University of New York , Buffalo , NY , USA.
Publikováno v:
MAbs [MAbs] 2017 Jan; Vol. 9 (1), pp. 15-28. Date of Electronic Publication: 2016 Sep 23.
Autor:
Chudasama VL; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York (V.L.C., M.A.O., D.E.M.); and Office of Clinical Pharmacology, Food and Drug Administration, Silver Springs, Maryland (D.R.A.)., Ovacik MA; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York (V.L.C., M.A.O., D.E.M.); and Office of Clinical Pharmacology, Food and Drug Administration, Silver Springs, Maryland (D.R.A.)., Abernethy DR; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York (V.L.C., M.A.O., D.E.M.); and Office of Clinical Pharmacology, Food and Drug Administration, Silver Springs, Maryland (D.R.A.)., Mager DE; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York (V.L.C., M.A.O., D.E.M.); and Office of Clinical Pharmacology, Food and Drug Administration, Silver Springs, Maryland (D.R.A.) dmager@buffalo.edu.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2015 Sep; Vol. 354 (3), pp. 448-58. Date of Electronic Publication: 2015 Jul 10.
Autor:
Euling SY; National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA. Electronic address: euling.susan@epa.gov., White LD, Kim AS, Sen B, Wilson VS, Keshava C, Keshava N, Hester S, Ovacik MA, Ierapetritou MG, Androulakis IP, Gaido KW
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2013 Sep 15; Vol. 271 (3), pp. 349-62. Date of Electronic Publication: 2011 Jun 30.
Autor:
Ovacik MA; Chemical and Biochemical Engineering Department, Rutgers University, Piscataway, NJ 08854, USA., Androulakis IP
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2013 Sep 15; Vol. 271 (3), pp. 363-71. Date of Electronic Publication: 2010 Sep 17.
Autor:
Ovacik MA; Chemical and Biochemical Engineering Department, Rutgers University, Piscataway, NJ 08854, USA., Sen B, Euling SY, Gaido KW, Ierapetritou MG, Androulakis IP
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2013 Sep 15; Vol. 271 (3), pp. 386-94. Date of Electronic Publication: 2010 Sep 17.
Autor:
Iyer VV; Dept. of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA., Ovacik MA, Androulakis IP, Roth CM, Ierapetritou MG
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2010 Nov 01; Vol. 248 (3), pp. 165-77. Date of Electronic Publication: 2010 Jul 24.